Pathology/Lab Coding Alert

Reader Question:

Correction: V58.83 is Primary Diagnosis

Question: Which ICD-9 code(s) should we use when billing for a PT test to monitor Coumadin therapy? I read in a past issue of your newsletter [Vol. 10, No. 5] that you should list V58.61 first, not the underlying condition. But ICD-9 lists V58.61 as a secondary diagnosis -- what should we do? New York Subscriber Answer: You are correct that ICD-9 lists V58.61 (Long-term [current] use of anticoagulants) as a secondary diagnosis. However, the article you referenced correctly states that you shouldn't list first the underlying condition when the reason for the prothrombin time (PT) test is to monitor the effectiveness of anticoagulation medication. A change to the laboratory national coverage determination (NCD) for PT now lists V58.83 (Encounter for  therapeutic drug monitoring) as a covered diagnosis. ICD-9 instruction for that code states, "Use additional code for any associated long-term (current) drug use (V58.61- V58.69)." If the reason for the [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Pathology/Lab Coding Alert

View All